Lipopolysaccharides (LPSs) from Escherichia coli, Serratia marcescens, and SabnoneUa typhimurium, at doses from 1 to 100 ng/ml, strongly enhanced growth inhibition of Candida albicans by human polymorphonuclear leukocytes (PMN) [24, 38] ) and secretion of oxygen metabolites, inflammatory factors, hydrolases, and lactoferrin (18, 20, 21, 25) . Increases in microbial killing and migration are also commonly observed in LPS-stimulated PMN (6, 7), and augmented production of platelet activation factor and leukotrienes has been reported (14, 44).
Lipopolysaccharides (LPS; endotoxins) are among the most powerful bacterial products, endowed with proinflammatory and immunomodulatory properties (31, 39) . In particular, LPS induce a variety of responses in monocytes and polymorphonuclear cells (PMN; neutrophils) both in vitro and in vivo (5, 8, 22) , of which some may be related to the mechanism of endotoxic shock, a severe clinical entity (29, 43) , as well as to other manifestations of LPS activity in the pathophysiology of infections (31, 46) . Among the neutrophil responses primed by endotoxin are the enhanced expression of adherence-related membrane glycoproteins (such as the CD11-CD18 family [24, 38] ) and secretion of oxygen metabolites, inflammatory factors, hydrolases, and lactoferrin (18, 20, 21, 25) . Increases in microbial killing and migration are also commonly observed in LPS-stimulated PMN (6, 7) , and augmented production of platelet activation factor and leukotrienes has been reported (14, 44) .
Although neutrophils have long been considered terminally differentiated cells incapable of synthesizing or secreting proteins, recent but conclusive data have shown that these phagocytic cells are able to synthesize and secrete interleukin-1 (IL-1) and tumor necrosis factor (TNF) (12, 15, 26, 28) . These cytokines have multiple effects on neutrophil functions, including increased migration, priming for en-hanced oxidative metabolism, and sustained phagocytosis and killing of fungal cells (9, 16, 36, 37) .
In view of these observations, and because of our interest in the mechanisms of immune response to the dimorphic opportunistic fungus Candida albicans, we have investigated here the effect of LPS on the anti-Candida activity of neutrophils from normal human donors, with the aim of understanding the mechanisms underlying LPS activation of PMN candidastatic and/or candidacidal activity. Three different bacterial sources of LPS were used to confirm their uniform stimulating effect on neutrophil function. In addition, we investigated whether this stimulation could be correlated with the ability of PMN to produce cytokines and secrete lactoferrin, an iron-binding antimicrobial protein (23, 32, 35) .
MATERIALS AND METHODS
Preparation of human PMN. Leukocyte buffy coats, obtained from normal volunters at the South West Florida blood bank (Tampa, Fla.), were diluted 1:2 in phosphatebuffered saline (PBS), and 35 to 40 ml was layered on 10 ml of Ficoll-Hypaque solution (Pharmacia Fine Chemicals, Piscataway, N.J.). After centrifugation for 30 min at 400 x g at room temperature, the leukocyte layer lying on the surface of the erythrocyte pellet was collected, and the erythrocytes were lysed by hypotonic shock with sterile distilled water (30 s at room temperature). The Phagocytosis. To measure the phagocytic activity of neutrophils, a flow cytometric assay based on the uptake of FITC-labeled C. albicans was used as modified from a previously established procedure to quantitate fluorescentparticle phagocytosis by monocytes (42) . Briefly, 106 neutrophils in a final volume of 150 ,ul of FBS medium were untreated or treated with 100 ng of LPS per ml for 30 min at 37°C. Then, 20 pl of FITC-labeled C. albicans at 5 x 108/ml was added to each sample, and the mixture was vortexed and incubated for 30 min at 37°C. Finally, 1 ml of warm PBS was added to each tube before the fluorescence of ingested yeasts within neutrophils was read with a FACScan (Becton Dickinson, Mountain View, Calif.). The yeast-PMN mixture was gated to exclude free FITC-labeled C. albicans from the measurement. A solution of trypan blue (1%, wt/vol) was added to the samples in order to quench the fluorescence of possible C. albicans yeasts adhered to the outside of the PMN. It was found that 20 p,l of 1% trypan blue was optimal for quenching the fluorescence of FITC-labeled C. albicans alone in 1 ml of FBS medium. Others have used crystal violet for FITC quenching, but trypan blue proved to be at least equally effective (3). Data were analyzed in terms of light scatter and fluorescence intensity so as to distinguish PMN with internalized fluorescent cells from nonphagocytizing PMN, as well as the degree of phagocytosis per single PMN, as indicated by the average fluorescence intensity. An aliquot of the same cell samples was cytocentrifuged and stained with Giemsa to check visually for phagocytosis under the light microscope. buffer (pH 9.6). The plates were washed with PBS supplemented with 0.05% Tween 20 (Sigma Chemical Co.). The test supernatants, diluted 1:10 or 1:30 in PBS supplemented with 0.1% bovine serum albumin, were applied in triplicate and left overnight at 4°C. Serial dilutions of human lactoferrin from 1,000 to 1 ng/ml were applied in triplicate to fit a standard curve. After extensive washing, alkaline phosphatase-conjugated, affinity-purified rabbit anti-human lactoferrin (Jackson Immuno Research Laboratories Inc., West Grove, Pa.) was added to each well. After incubation at 37°C for 90 min and washing, a phosphatase substrate (Sigma) was added, and the developed color was read at 405 nm on an ELISA reader. Results were calculated from sigmoidal standard curves by using the spline curve-fitting method of the Riacalc program (Pharmacia Wallac Oy, Turku, Finland). This ELISA detected up to less than 10 ng of lactoferrin per ml. It did not detect transferrin, and no interference was seen with the constituents of FBS medium, which was used as a blank in the assay.
TNF assay. TNF was titrated by measuring the lysis of the TNF-sensitive murine cell line WEHI-164 (9) . Cells from an exponentially growing culture of WEHI-164 cells were pelleted in a 5-ml sterile plastic tube, and 100 p.Ci of radiolabeled sodium chromate (Na[51Cr]04; Amersham, Arlington Heights, Ill.) was added for 1 h at 37°C. The cells were then washed three times and adjusted to 5 x 104 cells per ml. Then, 100 ,ul of the labeled WEHI-164 tumor cells was added to 100 ,ul of the serial dilution of TNF-containing culture supernatants, and after 18 h at 37°C, the 51Cr released in the supernatants from lysed target cells was harvested and counted in a gamma counter. Maximum isotope incorporation was determined by counting the radioactivity in target cells alone, and spontaneous release was measured by counting the radioactivity in supernatants of target cells incubated with medium alone.
The spontaneous release in the 18-h assay was always in the range of 18 to 25%. Serial dilutions of a standard human recombinant TNF-a (Genentech Corp., South San Francisco, Calif.) were included as a control, and the concentration of TNF in the samples was calculated from the standard curve.
IL-1,l and IL-6. To quantitate the production of interleukin-1o (IL-1,) and IL-6 by PMN, a commercially available ELISA (Quantikine Research and Diagnostic System, Minneapolis, Minn.) was used. The data were analyzed as instructed by the developer of the ELISA and calculated by using the spline curve-fitting method of the Riacalc program (see above).
Treatment with emetine and cycloheximide. Neutrophils suspended to 106/ml in FBS medium were treated with emetine or cycloheximide for 1 h at 37°C, at concentrations (10-5 M and 200 ,ug/ml, respectively) sufficient to inhibit all protein synthesis (13, 18) . The cells were washed twice in warm PBS, evaluated for viability by trypan blue exclusion, and resuspended to the desired number in FBS medium to assay for anti-Candida activity and release of lactoferrin or TNF in their supernatants, as described above.
Preparation of RNA. Neutrophils were cultured in FBS medium at 3 x 106 cells per ml at 37°C for 1 or 3 h with 100 ng of LPS per ml. Neutrophils cultured for 1 h without LPS served as the control. Total RNA was prepared by the method of Chomzynski and Sacchi (4) by acid guanidinum thiocyanate-phenol-chloroform extraction.
Northern (RNA blot) analysis. For each sample, 20 p,g of total RNA was subjected to gel electrophoresis with 0.8% agarose (Bethesda Research Laboratories, Rockville, Md.). . Hybridization was performed in an identical solution supplemented with 2 x 106 cpm of a 32P-labeled TNF-a cDNA probe (Genentech Corp.), IL-11 cDNA probe, or IL-6 cDNA probe (kindly provided by Steven Clark, Genetics Institute, Cambridge, Mass.) per ml at 45C overnight. The probes were labeled with [3 P]dCTP (specific activity, 3,000 Ci/mmol; New England Nuclear, Boston, Mass.) with a Random Primed DNA labeling kit (Boehringer-Mannheim Biochemicals, Indianapolis, Ind.). The membranes were washed twice in lx SSC at 60°C for 30 min and exposed to Kodak X Omat-Ar films with an intensifying screen for 3 days for the TNF-a and IL-6 probes and for 4 h for the IL-1" probe.
Statistical analysis. Statistical analysis of the data was done with Student's t test or the Mann-Whitney U test, as appropriate.
RESULTS
Effect of various LPS on neutrophil anti-Candida activity.
We tested the effect of three different LPS isolated from the cell walls of E. coli, S. marcescens, and S. typhimurium.
Graded concentrations of each LPS were added to neutrophils before addition of the target cells (C. albicans) to yield E:T ratios of 60:1, 30:1, and 15:1. For all donor cells tested, LPS in a dose range from 1 to 1,000 ng/ml strongly enhanced the anti-Candida activity of human neutrophils. For most PMN donors, optimal stimulation was achieved at an LPS concentration of 10 ng/ml, and there were no statistically significant differences, at least at the highest E:T ratio, in the growth inhibition measured at 10, 100, and 1,000 ng of LPS per ml. For instance, for the particular donor cells shown in Fig. 1 , at E:T ratios of 15:1 and 60:1, LPS at 10 ng/ml increased the anti-Candida activity to about 50 and 90% growth inhibition from 20 and 60%, respectively. Over the same range of doses (1 to 1,000 ng/ml) and at all E:T ratios Effect of LPS on phagocytic activity. By using a flow cytometric assay based on the uptake of FITC-labeled C. albicans by neutrophils (42), as well as direct microscopic observations of Giemsa-stained cytocentrifuge preparations, it was possible to show that LPS enhanced neutrophil phagocytosis by increasing both the percentage of cells able to ingest C. albicans and the number of yeasts ingested per neutrophil. Figure 3 shows the data from three experiments (three donors) with the FACScan. Both the percent phagocytosing neutrophils (Fig. 3B) and the fluorescence intensity representative of the average number of Candida cells ingested per neutrophil (Fig. 3A) lactoferrin released after 1 h closely approached the total amount detected in unstimulated controls after 24 h. Overall, the amount of lactoferrin detected in cultures of neutrophils stimulated by LPS was always significantly higher, at every time point tested, than that in unstimulated cultures and increased in a time-dependent manner. The LPS from S. marcescens and S. typhimurium were also able to promote lactoferrin release from secondary granules (data not shown).
Ability of lactoferrin itself to inhibit Candida growth and its importance in the anticandidal activity of neutrophils. Since lactoferrin acts as a bacteriostatic agent (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) , and, as shown by the results in the preceding sections, it was released in appreciable amounts during LPS stimulation, we examined whether lactoferrin had a direct effect on the growth of C. albicans. By the same rapid [3H]glucose uptake assay used to assay lysis of PMN, we found that this iron-binding protein was able to inhibit C. albicans growth in a dose-dependent manner over a range from 1 to 100 p,g/ml.
At the highest lactoferrin dose, fungal growth was inhibited by about 70%. The ability of lactoferrin to inhibit Candida growth at any dose tested was completely abolished by using antilactoferrin serum at a 1:100 dilution. Transferrin and antitransferrin serum were also used in the same range of doses, but transferrin showed no effect on Candida growth, and antitransferrin antibodies were unable to reverse the growth-inhibitory effect of lactoferrin (Table 2) . Consequently, we used rabbit anti-human lactoferrin antibodies in the anti-Candida PMN assay to ascertain whether these antibodies could also inhibit the neutrophil anti-Candida activity stimulated by LPS. In these experiments, a 1:1,000 dilution of antilactoferrin serum was used, which could neutralize the inhibitory effects on Candida growth obtained with 10 p,g of lactoferrin (Table 2 ). Figure 4 shows the results from one of two experiments performed with similar results. The antilactoferrin antibodies decreased the anti-Candida activity of unstimulated neutrophils as well as that of neutrophils stimulated by LPS (100 ng/ml), especially at the lowest E:T ratio, where growth inhibition was reduced from 78.4% + 5% to 23 antitransferrin serum, used at the same dilution (1:50) as in the experiments reported in Table 2 , was unable to reverse the ability of PMN to inhibit the growth of C. albicans (data not shown: see also the results in Table 2 ). Synthesis of cytokines by neutrophils. In view of the recently discovered ability of neutrophils to synthesize various cytokines with potential antimicrobial activity (12, 15, 26, 28) , we examined whether PMN were able to produce cytokines such as IL-1f, TNF-ca, and IL-6 in response to LPS under the conditions of our anti-Candida assay. All three cytokines were readily detected in the supernatants of PMN activated with LPS (100 ng/ml). Figure 5 indicated a peak of TNF-a production at about 6 h, while IL-15 and IL-6 were still on the rise at 24 h. Similarly, Northern blot analysis (Fig. 6 ) revealed the efficient ability of neutrophils to synthesize mRNAs for the three cytokines. Unstimulated PMN produced some cytokine-specific mRNA, but the degree of cytokine gene transcription was greatly augmented by LPS stimulation. Peak mRNA transcription was detected after 1 h of LPS stimulation. In keeping with the Northern blot data, unstimulated neutrophils constitutively produced a background level of TNF, IL-10, and IL-6. Dose-response experiments showed that PMN released maximal TNF after stimulation with 100 to 1,000 ng of LPS per ml (data not shown). LPS isolated from other sources also stimulated the production of TNF. In a typical experiment, LPS from E. coli, S. marcescens, and S. typhimurium, used at 100 ng/ml, stimulated the production of 33 ± 0.3, 30 + 0.7, and 20 ± 1.0 (mean ± SEM) pg of TNF per ml, respectively, from PMN.
Effect of inhibitors of protein synthesis on neutrophil function. The data in the previous section demonstrate that PMN are biosynthetically active during the expression of antiCandida activity in vitro and that this biosynthetic activity is stimulated by LPS. In this line, it was of interest to examine whether inhibition of protein synthesis, presumably blocking cytokine production, could affect one or more aspects of PMN activation by LPS. Thus, neutrophils were incubated for 1 h at 37°C in FBS medium with or without emetine or cycloheximide, washed twice, and then stimulated or not with LPS (100 ng/ml) before anti-Candida activity, lactoferrin release, and TNF production were assessed. Figure 7 shows that neither drug significantly inhibited the antiCandida activity of either unstimulated or LPS-stimulated PMN, nor did they reduce the release of lactoferrin. As expected, however, these drugs almost totally abrogated TNF production (Fig. 6) . Similar results were obtained in other two experiments with different PMN donors, and the inhibitors of protein synthesis did not affect the viability of PMN per se (data not shown).
DISCUSSION
The goal of the present study was to unravel the various effects exerted by LPS on human PMN in vitro, in terms of both anti-Candida activity and stimulation of cytokine production. We have shown that indeed three kinds of LPS isolated from different bacteria were able to consistently potentiate the anti-Candida activity of human neutrophils. The activation by LPS was seen to occur at doses ranging from 1 to 1,000 ng/ml, but with PMN from most donors, 10 ng of LPS per ml was sufficient to give maximal (or nearly so) PMN activation. Remarkable differences between unstimulated and LPS-stimulated cells were found in the release of lactoferrin after 60 min. We have also demonstrated that LPS induced the transcription of mRNAs for TNF-a, We have demonstrated here that lactoferrin itself can inhibit, although not totally, the growth of C. albicans, and antibodies against human lactoferrin were able to completely reverse this inhibition. In addition, it is unlikely that the augmented anti-Candida activity observed after stimulation with LPS is due to enhanced PMN disruption or death, as these cells transcribed and translated cytokine genes efficiently during LPS activation, in a process that was totally inhibited by inhibitors of protein synthesis.
The sensitivity of C. albicans to lactoferrin gains more biological importance when the presence of this protein in biological fluids, including breast milk, plasma, saliva, tears, and pancreatic juice, is considered. Lactoferrin levels in plasma are known to increase during inflammation, accompanied by a decrease in the lactoferrin content of PMN (19, 45) . Lactoferrin is stored in secondary granules, and several cytokines as well as LPS are able to induce its release (1, 25) . Further studies are needed to know whether other proteins released by PMN could potentiate and act in concert with lactoferrin in inhibiting Candida growth and whether this activity relies only on the depletion of iron in the medium.
Because neutrophils are able to synthesize TNF and IL-1 (12, 15, 26, 28) , we investigated the possibility that PMN could produce other cytokines. The finding that neutrophils are able to produce IL-6 may be particularly relevant for the "immunomodulatory" properties of PMN, because these cells, through the production of IL-6, may be able to participate in the modulation of several B-and T-lymphocyte responses (17, 40) . We were particularly interested in examining whether the ability of LPS-primed PMN to produce IL-1, TNF-ct, and IL-6 correlated with their increased candidastatic potential and/or release of lactoferrin. We observed that the expected blockade of TNF production by (37a) .
The rapid antimicrobial response of neutrophils and the synthesis of cytokines could be a first process in preventing microbial invasion and a rapid way to recruit other inflammatory cells. Overall, it is worth emphasizing that neutrophils can produce the same cytokines attributed to monocytes, but because of their prompt delivery to the site of inflammation, PMN responses in vivo could be far more rapid than those of monocytes. All this further stresses the main role that is currently attributed to PMN in the control of tissue invasion by C. albicans and the critical importance of neutropenia in the development of deep-seated candidiasis (34) . 
